130683569	130683569	CD	B-NP	O
|	|	NN	I-NP	O
DMC	DMC	NN	I-NP	O
|	|	NN	I-NP	O
35220680	35220680	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3929917	3929917	CD	B-NP	O
|	|	CC	I-NP	O
3/30/2004	3/30/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Atrial	Atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
Heart	Heart	NN	B-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/10/2004	1/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2004	1/18/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
NAUMANN	NAUMANN	NNP	B-NP	O
,	,	,	O	O
EDWIN	EDWIN	NNP	B-NP	O
Z	Z	NNP	I-NP	O
678-98-88-9	678-98-88-9	CD	I-NP	O
Son	Son	NNP	I-NP	O
Portgas	Portgas	NNP	I-NP	O
Cleve	Cleve	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
4/25/04	4/25/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MODUGNO	MODUGNO	NNP	B-NP	O
,	,	,	O	O
DALTON	DALTON	NNP	B-NP	O
CORY	CORY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
SIDDIQUI	SIDDIQUI	NNP	B-NP	O
,	,	,	O	O
AUBREY	AUBREY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98265180	98265180	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
INR	INR	NNP	B-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
NEALE	NEALE	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
CLAR	CLAR	NN	B-NP	B-protein
,	,	,	O	O
LOWELL	LOWELL	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
47629983	47629983	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
following	follow	VBG	B-PP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
OBENG	OBENG	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
14173993	14173993	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ERYTHROMYCIN	ERYTHROMYCIN	NN	I-NP	B-protein
333	333	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
X	X	SYM	O	I-protein
8	8	CD	B-NP	I-protein
Days	Day	NNPS	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/8	10/8	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
complete	complete	JJ	B-NP	O
course	course	NN	I-NP	O
started	start	VBN	B-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
non-enteric	non-enteric	JJ	I-NP	O
coated	coated	JJ	I-NP	O
form	form	NN	I-NP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
TUCEK	TUCEK	NN	B-NP	B-protein
,	,	,	O	O
DOMINICK	DOMINICK	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
77564887	77564887	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
MARTINCIC	MARTINCIC	NN	B-NP	O
,	,	,	O	O
NICKY	NICKY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27813540	27813540	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
RIPPLE	RIPPLE	NN	B-NP	O
,	,	,	O	O
AGUSTIN	AGUSTIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41083371	41083371	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
--	--	:	O	O
1/2	1/2	CD	B-NP	O
load	load	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
ROWSER	ROWSER	NN	B-NP	O
,	,	,	O	O
IRVIN	IRVIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
96227238	96227238	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
EMLING	EMLING	NNP	B-NP	O
,	,	,	O	O
CORNELL	CORNELL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98265180	98265180	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
INR	INR	NNP	B-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/8	10/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
40mg	40mg	NN	I-NP	O
in	in	IN	B-PP	O
afternoon	afternoon	NN	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
FURCH	FURCH	NN	B-NP	B-protein
,	,	,	O	O
CORY	CORY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
NPH	NPH	NN	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
35	35	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
qam	qam	NN	I-NP	O
and	and	CC	O	O
qhs	qh	NNS	B-NP	O
SYNTHROID	SYNTHROID	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
DEBERRY	DEBERRY	NN	B-NP	O
,	,	,	O	O
BENJAMIN	BENJAMIN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
77564887	77564887	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
LUDGATE	LUDGATE	NN	B-NP	O
,	,	,	O	O
BLAKE	BLAKE	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27813540	27813540	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
BUNKLEY	BUNKLEY	NN	B-NP	O
,	,	,	O	O
HERSCHEL	HERSCHEL	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41083371	41083371	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
--	--	:	O	O
1/2	1/2	CD	B-NP	O
load	load	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
KNUCKLES	KNUCKLES	NNP	B-NP	O
,	,	,	O	O
JULIO	JULIO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
96227238	96227238	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
GSCHWEND	GSCHWEND	NNP	B-NP	O
,	,	,	O	O
WILMER	WILMER	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
98265180	98265180	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
Q5MIN	Q5MIN	NN	I-NP	I-protein
X	X	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
VITAMIN	VITAMIN	NNP	I-NP	I-protein
E	E	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
400	400	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/8	10/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
nights	night	NNS	I-NP	O
;	;	:	O	O
then	then	RB	O	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kendra	Kendra	NNP	I-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/04	2/13/04	CD	B-NP	O
by	by	IN	B-PP	O
MAZIQUE	MAZIQUE	NNP	B-NP	O
,	,	,	O	O
KIP	KIP	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
INR	INR	NNP	B-NP	O
MVI	MVI	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

12.5	12.5	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tonight	Tonight	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/3	3/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
QAC	QAC	NNP	I-NP	O
&	&	CC	I-NP	O
HS	HS	NNP	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Ledy	Ledy	NNP	I-NP	O
Office	Office	NNP	I-NP	O
-	-	:	O	O
follow-up	follow-up	NN	B-NP	O
for	for	IN	B-PP	O
foot	foot	NN	B-NP	O
10/19/04	10/19/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hubenthal	Hubenthal	NNP	I-NP	O
office	office	NN	I-NP	O
-	-	HYPH	O	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
3/2/04	3/2/04	CD	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Zwack	Zwack	NNP	I-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
8/3/04	8/3/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bud	Bud	NNP	I-NP	O
Decenzo	Decenzo	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Cephalosporins	Cephalosporins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NNP	B-NP	O
,	,	,	O	O
TRIMETHOPRIM	TRIMETHOPRIM	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atrial	Atrial	NNP	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
Heart	Heart	NN	B-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
Diastolic	Diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
Hypothyroidism	Hypothyroidism	NNP	B-NP	O
Obesity	Obesity	NNP	I-NP	O
,	,	,	O	O
Chronic	Chronic	NNP	B-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x4	x4	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
ECHO	ECHO	NN	B-NP	B-protein
,	,	,	O	O
Cardiac	Cardiac	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
Adenosine	Adenosine	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
80F	80F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x4	x4	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
EF	EF	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
p/w	p/w	NN	I-NP	O
2	2	CD	I-NP	O
d	d	NN	I-NP	O
of	of	IN	B-PP	O
stuttering	stutter	VBG	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
Afib	Afib	NN	B-NP	B-protein
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
c/o	c/o	JJ	B-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
wt	wt	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
energy	energy	NN	B-NP	O
.	.	.	O	O

Day	Day	NN	B-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
noted	note	VBN	B-VP	O
increased	increase	VBD	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
sob	sob	NN	I-NP	O
that	that	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
slowly	slowly	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
DOA	DOA	NN	B-NP	B-protein
,	,	,	O	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

ED	ED	VBN	B-VP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
in	in	IN	B-PP	O
SR	SR	NN	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
given	give	VBN	B-NP	O
NTG	NTG	NN	I-NP	O
x1	x1	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
dropped	drop	VBD	B-VP	O
in	in	RB	B-ADVP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
's	's	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sig	sig	NN	I-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
.	.	.	O	O

Then	Then	RB	O	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
Afib	Afib	NN	B-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
CK	CK	NN	B-NP	O
1000	1000	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
flat	flat	JJ	I-NP	O
MB	MB	NN	I-NP	O
and	and	CC	I-NP	O
TnI	TnI	NN	I-NP	B-protein
,	,	,	O	O
BNP	BNP	NN	B-NP	O
180	180	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
1.5	1.5	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
floor	floor	NN	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
increased	increase	VBN	B-NP	O
CP	CP	NN	I-NP	B-DNA
with	with	IN	B-PP	O
HR	HR	NN	B-NP	O
110	110	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
slowed	slow	VBD	B-VP	O
with	with	IN	B-PP	O
lopressor	lopressor	NN	B-NP	B-protein
iv	iv	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain/CAD	Pain/CAD	NNP	I-NP	O
:	:	:	O	O
ECG	ECG	NN	B-NP	O
without	without	IN	B-PP	O
sig	sig	NN	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
for	for	IN	B-PP	O
?	?	.	O	O

unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ntg	ntg	NN	B-NP	O
,	,	,	O	O
maalox	maalox	NN	B-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
stopped	stop	VBD	B-VP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
elevations	elevation	NNS	I-NP	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
statin	statin	NN	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
Zocor	Zocor	NNP	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Afib	Afib	NNP	I-NP	O
:	:	:	O	O
Known	Know	VBN	B-VP	O
history	history	NN	B-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
LA	LA	NN	B-NP	O
4.8	4.8	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
beta-blockade	beta-blockade	NN	I-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
will	will	MD	B-VP	O
d/c	d/c	VB	I-VP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
>	>	SYM	I-NP	O
L	L	NN	I-NP	B-protein
HF	HF	NN	I-NP	I-protein
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
iv	iv	NN	I-NP	O
bid	bid	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
lost	lose	VBN	B-NP	O
5kgs	5kg	NNS	I-NP	O
.	.	.	O	O

Feeling	Feel	VBG	B-VP	O
better	good	JJR	B-NP	O
s/p	s/p	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-DNA
7/26	7/26	CD	I-NP	I-DNA
showed	show	VBD	B-VP	O
preserved	preserve	VBN	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
PA	PA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
BPs	BP	NNS	B-NP	B-protein
slighly	slighly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
on	on	IN	B-PP	O
B-blocker	B-blocker	NNP	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
d/c	d/c	VB	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80po	80po	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
addnl	addnl	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
NPH/RISS	NPH/RISS	NNP	I-NP	O
.	.	.	O	O

HgA1c	HgA1c	NN	B-NP	B-protein
7.3	7.3	CD	I-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Hypothyroid	Hypothyroid	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
synthroid	synthroid	NN	B-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	O
nl	nl	NN	I-NP	O
.	.	.	O	O

D/c	D/c	NN	B-NP	O
home	home	NN	I-NP	O
7/26	7/26	CD	I-NP	O
,	,	,	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
for	for	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
ASMH	ASMH	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Denapoli	Denapoli	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Please	Please	NNP	I-NP	I-protein
keep	keep	VB	B-VP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
already	already	RB	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
tomorrow	tomorrow	NN	B-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
also	also	RB	B-ADVP	O
go	go	VBP	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Atmore	Atmore	NNP	I-NP	O
office	office	NN	I-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
test	test	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	B-VP	O
If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	I-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
seek	seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BOWMAN	BOWMAN	NNP	B-NP	O
,	,	,	O	O
WADE	WADE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BL262	BL262	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/25/04	4/25/04	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
18	18	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

